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Abstract
Background: Severe malarial anaemia is a major complication of malaria infection and is multi-
factorial resulting from loss of circulating red blood cells (RBCs) from parasite replication, as well
as immune-mediated mechanisms. An understanding of the causes of severe malarial anaemia is
necessary to develop and implement new therapeutic strategies to tackle this syndrome of malaria
infection.
Methods: Using analysis of variance, this work investigated whether parasite-destruction of RBCs
always accounts for the severity of malarial anaemia during infections of the rodent malaria model
Plasmodium chabaudi in mice of a BALB/c background. Differences in anaemia between two different
clones of P. chabaudi were also examined.
Results: Circulating parasite numbers were not correlated with the severity of anaemia in either
BALB/c mice or under more severe conditions of anaemia in BALB/c RAG2 deficient mice (lacking
T and B cells). Mice infected with P. chabaudi clone CB suffered more severe anaemia than mice
infected with clone AS, but this was not correlated with the number of parasites in the circulation.
Instead, the peak percentage of parasitized RBCs was higher in CB-infected animals than in AS-
infected animals, and was correlated with the severity of anaemia, suggesting that the availability of
uninfected RBCs was impaired in CB-infected animals.
Conclusion: This work shows that parasite numbers are a more relevant measure of parasite
levels in P. chabaudi infection than % parasitaemia, a measure that does not take anaemia into
account. The lack of correlation between parasite numbers and the drop in circulating RBCs in this
experimental model of malaria support a role for the host response in the impairment or
destruction of uninfected RBC in P. chabaudi infections, and thus development of acute anaemia in
this malaria model.
Background
Severe malarial anaemia (SMA) is a major factor contrib-
uting to malarial morbidity in humans (for review see
[1,2]) and is a significant pathological feature of most
rodent malaria infections [3]. During malaria infection,
destruction of red blood cells (RBCs) from parasite repli-
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However there also appears to be an interruption in the
normal flow of replacement RBCs, as well as the appear-
ance of abnormal RBCs (dyserythropoiesis) and prema-
ture destruction of uninfected RBCs
(erythrophagocytosis) [4-6] that will alter the total
number and relative effectiveness of RBCs in the circula-
tion (reviewed by [7]). Although it is known that the
severity of anaemia in malaria infection can be discordant
with parasite replication rates, the relative contributions
of RBC destruction through parasite replication and the
altered replacement and persistence of functional RBCs in
the circulation in SMA has not been formally assessed.
Similarly to human SMA, dyserythropoiesis and eryth-
rophagocytosis have been observed in mouse malaria
infection [8-10]. The pro-inflammatory response of the
host to the malaria parasite observed in both human
infections and mouse models [11-15] is thought to play a
role in these processes. Tumour necrosis factor-α (TNF-α)
[16-19] and macrophage migration inhibitory factor
(MIF) produced by immune cells, in particular macro-
phages [20,21], are thought to contribute to malarial
anaemia by suppressing erythroid development. Con-
versely, anti-inflammatory cytokines such as IL-10 may
play a protective role [12,22-24]. Therefore, it is possible
that under the conditions of natural malaria infections,
where differences between hosts in the magnitude or skew
of the immune response to malaria parasites can be
observed, the contribution of the different factors deter-
mining the severity of malarial anaemia may also be
altered.
The extent to which the number of parasitized RBCs
(pRBCs) in the circulation correlates with the severity of
malarial anaemia, or whether even in the early phase of a
blood stage infection there is evidence of involvement of
the host response in RBC destruction or suppression of
RBC synthesis, has been examined here using blood stage
infections of a mouse model of malaria, Plasmodium
chabaudi chabaudi, which replicates in a synchronous
manner approximately every 24 hours. Circulating para-
site numbers have been compared with haemoglobin
(Hb) levels and loss of RBC during P. chabaudi infections
in mice. Using RAG2-/- mice lacking T and B cells, and
two P. chabaudi clones (AS and CB) of differing virulence,
the data indicate that the level of anaemia does not corre-
late with the number of parasite-infected RBC. Further-
more, the greater loss of RBC in the more virulent
infection of P. chabaudi (clone CB) is not the result of a
greater parasite load, but rather a decrease in the number
of uninfected RBC. Therefore, an increase in the severity of
anaemia in P. chabaudi infections of BALB/c mice appears




Female BALB/c and BALB/c RAG2 deficient (RAG2-/-)
mice [25] aged 6 to 12 weeks were obtained from the SPF
breeding facility of the National Institute for Medical
Research, London, UK and maintained under conven-
tional conditions on a 12 hr light : dark cycle. All experi-
ments were carried out according to Home Office
requirements and under approval of the Ethical Commit-
tee of the National Institute for Medical Research.
Parasites and infection
Plasmodium chabaudi chabaudi clones AS and CB [26] were
maintained as frozen stabilates, and parasites from the
same passage were used in all experiments in this study.
Mice were injected intraperitoneally with 1 × 105 pRBCs
suspended in Kreb's saline and the course of parasitaemia
monitored by Giemsa-stained thin blood films obtained
from tail snips. The percentage of pRBCs was enumerated
from counting the number of infected RBCs in 300–500
RBCs per mouse for each time point. The number of circu-
lating parasitized RBC (pRBC or parasite numbers) were
calculated by multiplying the percentage of pRBCs by the
number of circulating RBCs (see below) for each mouse at
each time point. For all experiments each experimental
group comprised of five mice. Naive uninfected control
mice were included in all experiments and were injected
with Kreb's saline. Each experiment was repeated three
times.
Measurements of anaemia
The number of circulating RBCs was analysed by dilution
of 5 μl tail blood in 45 μl of Krebs saline containing 100
U/ml Heparin (Leo laboratories Ltd, UK) and the samples
read on a Hemavet machine (Drew Scientific) within
three hours of collection. Hb was measured by diluting 5
μl of blood in 100 μl Drabkin's solution (1 g NaHCO3,
0.1 g K2CO3, 0.05 g KCN and 0.2 g K3Fe(CN)6 in1 litre of
dH2O) freshly made before the start of each experiment.
The amount of cyanomethoglobin formed was read at
540 nm on an ELISA reader and converted to mg/ml using
a standard curve of rat Hb (Sigma). Measurements were
taken on day 0 of infection, and then daily from day 3 to
day 14, with a final measurement at day 19, all at the same
time of day (approximately 15.00 hr) when the number of
mature schizont stages was minimal.
Statistical analysis
As measures of anaemia, the greatest drop in the number
of circulating RBCs or in Hb over the course of infection
was calculated by subtracting daily measurements from
that measured at day 0 for each mouse. Parasitaemia was
analysed as the maximum number of circulating pRBCs or
percentage of pRBCs observed over the course of infection
for each animal. Total parasite load was calculated fromPage 2 of 9
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each animal using Prism software (Prism Inc). In each of
the three experiments carried out with the two different
clones of P. chabaudi, some animals infected with clone
CB died (collective values over the three experiments are
days 10, 12 and 15 PI: 1 animal per day; days 9 and 13 PI:
2 animals per day; day 11: 4 animals). Only one animal
infected with clone AS died at day 13 in experiment 1. For
all these animals the maximum values of parasitaemia
and anaemia recorded before death analysed.
Analysis of variance (ANOVA) (Minitab Inc.) [27] was
used to meta-analyse the combined data from three differ-
ent experiments. Experiment and a term to check for any
experimental interaction between the mouse strain or par-
asite clone were included as predictor factors to account
for between-experimental differences and verify that all
experiments reached the same conclusion. The naive ani-
mals were removed from all the statistical analyses since
they did not suffer any discernible anaemia. Analysis of
the residuals from the maximal model of the ANOVA con-
taining all first order interactions confirmed that the
transformed data accorded with the assumptions of para-
metric tests. The peak pRBC number for each mouse was
logarithmically transformed prior to analysis in order to
satisfy these requirements of parametric testing. In all
cases P values < 0.05 were considered statistically signifi-
cant and unless otherwise stated significant P-values are
from the minimal model; non-significant P-values are
from the models from which they were removed.
Results
The number of circulating pRBCs does not correlate with 
the severity of anaemia in either BALB/c or RAG2-/- 
animals over the first 9 days of infection
To determine whether parasite-mediated destruction of
RBC was responsible for the acute anaemia observed in P.
chabaudi AS infections, parasitaemia and anaemia were
compared in infected RAG2-/-, lacking T and B cells, and
immunocompetent BALB/c mice infected with P. chabaudi
clone AS. Since RAG2-/- are unable to control the growth
of malaria parasites and generally die of a fulminating
parasitaemia between 10 to 12 days post-infection [28]
measurements were taken only up to day 9 of infection,
prior to the peak of infection and before anaemia was
maximal.
As expected the peak number of pRBCs was consistently
higher in RAG2-/- animals compared with BALB/c control
mice (Figure 1a, mouse strain: F1,28 = 50.53 P = 0.000)
suggesting that the presence of an acquired immune sys-
tem contributed to control of parasite growth even at this
early stage. During this period, the drop in the number of
RBCs, but not the drop in Hb levels, was significantly
greater in RAG2-/- mice compared with BALB/c mice (Fig-
ures 1b and 1c, RBC loss: F1,26 = 6.14 P = 0.020, Hb drop:
F1,26 = 2.82 P = 0.105). Despite the greater loss of RBC in
RAG2-/- mice there was no significant correlation
between peak numbers of pRBC and the drop in circulat-
ing RBC for either RAG2-/- or BALB/c mice (Figures 1d
and 1e, F1,11 = 0.55 P = 0.475 and F1,11 = 1.79 P = 0.208
respectively) suggesting that parasite destruction alone
was not responsible for the reduction in RBC numbers.
Plasmodium chabaudi clone CB induces more anaemia 
than clone AS, despite a similar parasitaemia curve
It has been shown previously that the severity of anaemia
in mice infected with P. chabaudi varies with the clone of
P. chabaudi parasite used [29]. It was, therefore, of interest
to determine whether anaemia caused by different P.
chabaudi clones could be ascribed to an increase in direct
RBC destruction by the more virulent clone, CB. The loss
of RBC and numbers of circulating pRBC in P. chabaudi AS
and CB infections of BALB/c mice were compared.
Maximum loss of RBC occurred at a similar time in both
infections (Table 1; combined data over three experi-
ments: F1,26 = 3.48 P = 0.074), but was significantly greater
in mice infected with clone CB than clone AS (Figure 2a
and Table 1; combined data: F1,26 = 4.786 P = 0.037).
Unlike the loss of RBC, the maximum drop in Hb was not
consistently different between infections with P. chabaudi
AS or CB (Figure 2b and Table 1; interaction term between
clone and experiment: F 2,24 = 8.03 P = 0.002). The drop
in Hb concentration and drop in circulating RBC numbers
were not correlated with each other (F1,26 = 2.08 P = 0.161;
data not shown) indicating that the amount of Hb during
malaria infection may not be the same in every RBC when
comparing infection with AS and CB.
Despite the greater RBC loss in P. chabaudi CB infections,
the peak numbers of circulating pRBCs were not signifi-
cantly different in the two infections (Figure 2c and Table
1; combined data: F1,26 = 0.63 P = 0.435). The peak
number of circulating pRBCs occurred at similar times for
both clones although this was not uniform between the
three experiments (Table 1; interaction term between
experiment and clone F2,24 = 5.00 P = 0.015). Total para-
site load (as calculated by the area under the parasite
curve) similarly was not significantly different between
the clones (Table 1; combined data: F1,26 = 0.47 P =
0.497). Together these data indicate that clone CB induces
more anaemia than clone AS over the course of infection
in BALB/c mice, despite similar numbers of pRBC and a
similar parasite load.Page 3 of 9
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Comparison of anaemia and peak parasitaemia in P. chabaudi (AS) infected recombinase activating gene 2 -/- (RAG2-/-) and BALB/c miceFigure 1
Comparison of anaemia and peak parasitaemia in P. chabaudi (AS) infected recombinase activating gene 2 -/- (RAG2-/-) and BALB/c 
mice. a) Peak number of circulating pRBCs measured over the first 9 days of infection; b) Drop in the number of circulating RBCs and c) Drop in Hb level 
of the blood relative to day 0 measurements in BALB/c and BALB/c RAG2-/- animals. The bars in a) to c) represent the average, and the error bars the 
SEM, of the cumulative values of 15 BALB/c AS-infected animals (black square) 15 RAG2-/- AS- infected animals (open square) from 3 experiments. d) and 
e) Residual amount of anaemia (once experiment has been taken into account) in P. chabaudi infection of BALB/c mice (black circle) and RAG2-/- mice plot-
ted (open circle) against the peak number of circulating pRBCs for each mouse. In d) and e) the solid line represents the best-fit linear regression line. The 
dashed line highlights the residual anaemia observed once the data is normalized for experimental variation in the magnitude of RBC loss (ANOVA model 
"RBC loss = experiment"). Therefore the solid best-fit regression line shows the extent to which peak pRBC numbers correlate with the drop in circulat-
ing RBCs once experiment has been accounted for (residual change in RBC number). The black dots represent BALB/c animals and the white dots repre-
sent RAG2-/- animals.
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correlates with the drop in circulating RBCs in P. chabaudi 
infection
Although the number of circulating pRBCs in CB and AS
infections was not significantly different (Figure 2c and
Table 1), the maximum percentage of circulating pRBCs
in mice infected with clone CB was observed earlier and
was significantly higher than in AS-infected mice (Figure
2d and Table 1; Day of maximum parasitaemia combined
data: F1,26 = 0.63 P = 0.043, maximum percentage of
pRBCs combined data: F1,26 = 29.33 P = 0.000) indicating
that there were fewer RBC available for infection in CB
infections. In line with these data, the maximum percent-
age parasitaemia over the course of infection was strongly
correlated with anaemia (Figure 2e, peak percentage of
pRBCs F1,26 = 6.72 P = 0.015), whereas there was no cor-
relation between loss of RBC and peak number of pRBC
across both clones (Fig 2f, F1,24 = 0.00 P = 0.993). Together
these data suggest that parasite destruction of RBCs is not
a major factor leading to variation in anaemia within CB
and AS infections, and that lack of availability of RBCs
leading to higher percentage of pRBCs in CB infections
may explain the greater anaemia in this infection.
In contrast to the correlation of the peak percentage of
pRBCs with the drop in circulating RBCs, the peak
number of pRBCs (but not the peak percentage of pRBCs)
did correlate with drop in haemoglobin in the blood
(peak pRBC number combined data: F1,23 = 12.02 P =
0.000; peak percentage of pRBCs combined data: F1,22 =
0.43 P = 0.521). These results provide further evidence
that the two measures of anaemia (loss of RBC and Hb
levels) do not behave in the same manner, and again sug-
gest that RBCs in the circulation in malaria-infected mice
can contain different levels of Hb.
Discussion
The data from the experiments in this study indicate that
the acute severe anaemia accompanying a blood stage
infection with P. chabaudi in mice is not primarily the
result of direct parasite destruction of infected RBCs. In
particular, during infections with two clones of P.
chabaudi that differ in virulence, the drop in circulating
RBC numbers was clearly not associated with the total
number of circulating parasites, but rather with the per-
centage of infected RBCs suggesting that it is availability of
new RBC that is limiting in this infection model. As this
association also occurred in RAG2-/-immunodeficient
mice, the mechanism governing availability of RBCs do
not seem to require an adaptive immune response.
The reduced number of uninfected RBCs in acute P.
chabaudi infections could be the result of the host
response to the infection, which leads to impaired
replacement of RBC (erythropoiesis), the premature
destruction of uninfected RBCs (erythrophagocytosis) or
results in the production of defective RBCs (dyserythro-
poiesis) which would be removed by the reticular
endothelial system [7-10,30]. In P. chabaudi (AS) infec-
tions, impaired erythropoiesis has been shown to be due,
in part, to the reduced ability of RBC precursors to
respond to erythropoietin (EPO), resulting in limited
replacement of RBCs and thus exacerbation of anaemia
observed during infection [31]. An increase in the removal
of either infected RBC or erythrophagocytosis via opsoniz-
ing immunoglobulin cannot wholly explain RBC loss
described in this study, as a similar loss of RBC also occurs
in P. chabaudi RAG2-/- mice, in the absence of an acquired
immune system. However, it is still possible that comple-
ment components activated via the alternate pathway
could facilitate erythrophagocytosis by allowing the rec-
ognition of erythrocytes via macrophage complement
receptors [32]. Such a mechanism may normally facilitate
Table 1: Parasitaemia and anaemia data in primary P. chabaudi AS or CB infections of BALB/c mice.
CLONE Experiment 1 Experiment 2 Experiment 3
AS CB AS CB AS CB
AS CB AS CB AS CB
Peak Parasite Number (×109 /ml) (1) 3.9 ± 0.2 4.0 ± 0.5 1.5 ± 0.1 1.4 ± 0.2 2.1 ± 0.2 2.6 ± 0.3
Day of Peak Parasite Number (2) 10.8 ± 0.2 9.2 ± 0.2 9.0 ± 0.3 9.4 ± 0.4 7.0 ± 0.5 7.4 ± 0.4
Parasite Load ((pRBC × 109/ml)days) (1) 13.1 ± 1.3 16.4 ± 2.8 5.1 ± 0.6 3.1 ± 0.3 7.1 ± 0.5 6.0 ± 0.4
Peak % of pRBC (1,3) 30.1 ± 1.8 42.6 ± 0.9 23.3 ± 2.8 31.8 ± 1.9 33.4 ± 2.7 43.9 ± 3.6
Day of peak % of pRBC (1,3) 10.8 ± 0.2 9.2 ± 0.2 10.8 ± 0.2 10.6 ± 0.4 8.4 ± 0.4 8.2 ± 0.4
Maximum RBC loss (×109 /ml) (1,3) 7.4 ± 0.4 9.1 ± 0.5 11.5 ± 1.4 13.6 ± 0.9 9.2 ± 0.4 9.4 ± 0.3
Day of greatest loss in RBC (1) 11.6 ± 0.2 10.2 ± 0.4 11.2 ± 0.4 11.6 ± 0.5 9.6 ± 0.2 8.8 ± 0.4
Maximum Hg drop (mg/ml) (2) 54.8 ± 12.6 152.8 ± 22.8 210.4 ± 11.0 219.0 ± 9.8 230.4 ± 6.5 242.1 ± 4.7
Day of greatest Hg drop (1,3) 12.0 ± 0.8 10.4 ± 0.2 12.0 ± 0 11.6 ± 0.5 9.8 ± 0.4 9.0 ± 0.4
The values represent the averages ± SEM from 5 animals
1) Significant difference in magnitude between experiments (P < 0.05)
2) Significant difference in clonal behaviour between experiments (P < 0.05)
3) Significant difference between clones (P < 0.05)Page 5 of 9
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P. chabaudi clone CB induces more anaemia than clone AS in BALB/c miceFigure 2
P. chabaudi clone CB induces more anaemia than clone AS in BALB/c mice. a) Drop in the number of circulating 
RBCs; b) drop in the Hb level in the blood over the course of the primary infection; c) Number of circulating parasites and d) 
% of pRBC over the same time scale in AS-infected mice (black circle), CB-infected mice (open circle) and naive control ani-
mals (-). For each day the circles in a) to d) represent the average and the error bars the standard error of the mean (SEM) of 
5 animals from experiment 2. e) and f) residual number of circulating RBCs after experiment and clone have been taken into 
consideration plotted against peak percentage parasitemia (e) or peak number of pRBC (f) for all three experiments. Each sym-
bol represents the values for a single mouse infected with clone AS (black circle) or clone CB (open circle). The solid lines rep-
resent the best fit linear regression line in each case, and the dashed lines highlight the residual anaemia observed once the data 
is normalized for experimental and clonal variation in the magnitude of RBC loss (ANOVA model "RBC loss = experi-
ment+clone").
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immune conditions of a malaria infection.
Infection with the more virulent CB clone of P. chabaudi
resulted in a greater reduction in RBC number than the
less virulent clone AS, despite comparable numbers of
parasites (Figure 2c) and invasion rates (data not shown).
Across the AS and CB-infected BALB/c mice, pRBC num-
bers peaked between 1.4 -4 × 109 pRBCs with a concomi-
tant loss of 7.4 – 13.6 × 109 RBCs in circulation (Table 1).
Therefore, anaemia in P. chabaudi infections cannot be
entirely due to haemolysis of RBCs due to parasite replica-
tion. Since P. chabaudi can sequester in the liver [33], it is
possible that the circulatory pRBCs are not entirely repre-
sentative of parasite population numbers. However, this
was controlled for by measuring numbers of pRBCs at 3
pm in the normal light cycle, a time when the sequestering
schizont stage of P. chabaudi is not present in this synchro-
nous malarial infection [34,35]. Alternatively, it is possi-
ble that selective invasion of P. chabaudi for young
normocytes and reticulocytes may erode the replenish-
ment of circulating RBCs. However current evidence sug-
gests that P. chabaudi only invades younger cells when
more mature normocytes are in short supply [36]. Addi-
tionally, if this explained the clonal differences in the
severity of anaemia, we should concomitantly see differ-
ences in parasite load between the clones, with an
extended parasitaemia in one of the clones when normo-
cytes are in short supply. It seems more likely that it is the
differential induction of the host response by the CB clone
that is responsible for the greater degree of anaemia
observed in this infection.
Rodent malaria parasites can activate mouse macrophages
[37,38] to produce the cytokines IL-12 [37], TNF-α and
MIF [20] probably via recognition of parasite ligands by
pattern-recognition receptors (PRRs) [39]. These
cytokines have all been implicated in the immunopatho-
genesis of anaemia in mouse malaria infections [3]. It is
thus possible that the response of innate cells such as mac-
rophages, dendritic cells or NK cells could contribute to
the host response and therefore to anaemia. It would
therefore be of great interest to determine whether
impaired erythropoiesis or erythrophagocytosis in CB-
infected mice is greater than that measured in AS-infected
animals. Since the peak percentage of parasitaemia
occurred earlier in CB than in AS infections it might be
that an impaired response to EPO by erythroid progenitor
cells is detectable at an earlier time point in CB-infected
animals. A detailed examination of the nature of the host
response to the different P. chabaudi clones would clarify
whether cells of the innate system play a role in the devel-
opment of anaemia.
The discrepancy between the total number of circulating
parasites and the percentage parasitaemia in the clonal
infections described here highlights the need for caution
in the interpretation of percentage of infected RBC as a
measure of parasitaemia. Percentage parasitaemia is con-
founded by the level of anaemia and thus can be mislead-
ing as a determinant of parasite numbers. It appears that
the cause of the differences in anaemia between the two
clones is due to differences in the number of uninfected
RBCs in circulation in CB-infected and AS-infected mice.
An interesting finding of this study was that a reduction in
the number of circulating RBC did not necessarily corre-
late with a drop in the levels of Hb in the blood. Infected
RAG2-/- mice had lower circulating numbers of RBCs
than infected BALB/c, yet displayed similar levels of Hb.
Furthermore, there was no correlation between the drop
in RBC numbers and Hb in mice infected with either of
the two P. chabaudi clones. This finding may be related to
different levels of circulating reticulocytes between RAG2/
- and BALB/c animals, and between BALB/c animals
infected with clone AS or CB. Reticulocytes are elevated in
P. chabaudi AS infection as a response to the drop in circu-
lating RBC number [36]. Although we did not measure
circulating reticulocyte numbers in the infections in this
study, we would predict that both RAG2-/- AS-infected
animals, and BALB/c CB infected mice would have a
greater impairment of haematopoiesis and thus a lesser
number of reticulocytes in the circulation than AS-
infected BALB/c mice. If reticulocytes have reduced hae-
moglobin levels until they fully mature into RBCs, then it
follows that the AS-infected animals will have lower circu-
lating Hb levels relative to the number of circulating RBCs
compared with AS-infected RAG2-/- or CB-infected BALB/
c mice. Regardless, these results emphasize that any inves-
tigation of malarial anaemia should include more than
one measurement of anaemia.
Conclusion
In conclusion, we have found in this study that in the P.
chabaudi model of malarial anaemia, circulating numbers
of pRBCs do not always account for the severity of anae-
mia observed. Other mechanisms affecting adequate turn-
over and maintenance of RBC numbers in the circulation
appear to play a greater role in determining the severity of
anaemia in P. chabaudi infection than parasite destruction
of RBCs through replication. To understand the basis of
SMA, future research into the mechanisms governing RBC
generation in malaria infection is merited.
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